A newly described brain tumor type with long survival
Original title: Gliomas with pleomorphic and pseudopapillary features (GPAP) are circumscribed tumors with targetable mutations, prolonged survival, and frequent tumor predisposition.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
Doctors looked back at records from real patients, but no new treatment was tested.
The short version
Doctors found a brain tumor type that can look scary but often lets people live many years.
What was studied. Doctors gathered 20 brain tumors from several hospitals that seemed to match a newly proposed tumor type. They checked the tumor DNA, the scans, the tissue under the microscope, and how patients did over time.
What they found. All 20 tumors grouped together as one type. They had clear edges and did not spread far into nearby brain. Seven of them looked aggressive under the microscope, but ten years later an estimated 85% of patients were still alive. The typical age when the tumor was found was 37 years.
What this means, and what it doesn't
What it could mean: If your tumor matches this type, the long term outlook may be better than the microscope suggests. Naming the type correctly could help your doctors choose treatment. Some of these tumors had gene changes, such as BRAF: A gene in a pathway that tells cells to divide. Some tumors carry a change in it. There are drugs made to target that change, so your team may test for it. See the glossary, that drugs may be able to aim at. Five patients had inherited gene changes linked to a higher tumor risk, so family history may matter here.
What it doesn't mean: This is not a new treatment, and it is not a cure. It is an early report on a small group of 20 tumors, looking back at records rather than testing anything new. Doctors are still working out how to name and grade this tumor, so it may not be on your pathology report yet. Care in this study was not the same for everyone, so it does not tell you what treatment is best. It cannot promise how any one person will do.
Source: PubMed, September 29, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.